Novel Radiomic Measurements of Tumor- Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Purpose: Tumor-associated vasculature differs from healthy blood vessels by its chaotic architecture and twistedness, which promotes treatment resistance. Measurable differences in these attributes may help stratify patients by likely benefit of systemic therapy (e.g. chemotherapy). In this work, we present a new category of radiomic biomarkers called quantitative tumor-associated vasculature (QuanTAV) features, and demonstrate their ability to predict response and survival across multiple cancers, imaging modalities, and treatment regimens. Experimental Design: We segmented tumor vessels and computed mathematical measurements of twistedness and organization on routine pre-treatment radiology (CT or contrast-enhanced MRI) from 558 patients, who received one of four first-line chemotherapy-based therapeutic intervention strategies for breast (n=371) or non-small cell lung cancer (NSCLC, n=187). Results: Across 4 chemotherapy-based treatment strategies, classifiers of QuanTAV measurements significantly (p<.05) predicted response in held out testing cohorts alone (AUC=0.63-0.71) and increased AUC by 0.06-0.12 when added to models of significant clinical variables alone. QuanTAV risk scores were prognostic of recurrence free survival in treatment cohorts chemotherapy for breast cancer (p=0.002, HR=1.25, 95% CI 1.08-1.44, C-index=.66) and chemoradiation for NSCLC (p=0.039, HR=1.28, 95% CI 1.01-1.62, C-index=0.66). Categorical QuanTAV risk groups were independently prognostic among all treatment groups, including NSCLC patients receiving chemotherapy (p=0.034, HR=2.29, 95% CI 1.07-4.94, C-index=0.62). Conclusions: Across these domains, we observed an association of vascular morphology on radiology with treatment outcome. Our findings suggest the potential of tumor-associated vasculature shape and structure as a prognostic and predictive biomarker for multiple cancers and treatments.
Code (0)
등록된 구현이 없습니다.
Tasks
Experimental DesignSimilar Papers 제목 키워드 기반
Magnetic resonance delta radiomics to track radiation response in lung tumors receiving stereotactic MRI-guided radiotherapy
Introduction: Lung cancer is a leading cause of cancer-related mortality, and stereotactic body radiotherapy (SBRT) has become a standard treatment for early-stage lung cancer. However, the heterogeneous response to radi…
Radiogenomics of Glioblastoma: Identification of Radiomics associated with Molecular Subtypes
Glioblastoma is the most malignant type of central nervous system tumor with GBM subtypes cleaved based on molecular level gene alterations. These alterations are also happened to affect the histology. Thus, it can cause…
Prognostic Power of Texture Based Morphological Operations in a Radiomics Study for Lung Cancer
The importance of radiomics features for predicting patient outcome is now well-established. Early study of prognostic features can lead to a more efficient treatment personalisation. For this reason new radiomics featur…
Decision MakingSurvival AnalysisSynthetic Tumor Manipulation: With Radiomics Features
We introduce RadiomicsFill, a synthetic tumor generator conditioned on radiomics features, enabling detailed control and individual manipulation of tumor subregions. This conditioning leverages conventional high-dimensio…
Multi-Task LearningExploring Kinetic Curves Features for the Classification of Benign and Malignant Breast Lesions in DCE-MRI
Breast cancer is the most common malignant tumor among women and the second cause of cancer-related death. Early diagnosis in clinical practice is crucial for timely treatment and prognosis. Dynamic contrast-enhanced mag…
Prognosis